Загрузка...
Personalising your health: an EU imperative
In the fast-moving world of personalised medicine there are many issues and barriers—not least when it comes to getting novel drugs and treatments swiftly to where they are really needed. Slow bench-to-bedside rates do not help the 500 million potential patients across the EU’s current 28 Member Sta...
Сохранить в:
| Опубликовано в: : | Ecancermedicalscience |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Cancer Intelligence
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5533597/ https://ncbi.nlm.nih.gov/pubmed/28798813 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2017.ed68 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|